Can Hepatitis C Be Eliminated by 2030? On the Path to Zero

AbbVie’s broad commitment to a global effort to cure hepatitis C (HCV) led to a policy, advocacy and awareness initiative called Path to Zero: Fresh Thinking on the Road to Eliminating HCV.

A Scientist’s Retirement Plan: Sterilize Worms, Eliminate Neglected Diseases

Microscopic worms pulled them out of retirement – but does the urge to cure ever let you stop doing science?

Hepatitis C: The Mysterious Virus That Met its Match

The virus that brims with unanswered questions never stopped researchers from solving a few of its mysteries over the last 25 years.

Uniting for Parkinson's on the 200th Anniversary of the Disease

Four groups share why they must build unity to chart a better course for the future of Parkinson’s care.

Changing the Public Perception: Why Clinical Trial Participation is Needed

Clinical study participant Nina Martinez and AbbVie researcher Maurizio Facheris encourage people to help advance science by participating in clinical trials.

Eyeforpharma Awards AbbVie with 2017 “Most Valuable Patient Initiative" and “Most Valuable Pharma Collaboration”

Led by AbbVie Israel, more than 300 health care stakeholders across the country collaborated to build the awarded project, YouTube’s “Doctor’s Channel.”

Could Ireland Hold the Genetic Codes to Crack Serious Diseases?

Genomic information from thousands of people in Ireland may unearth new clues in the hunt for markers of disease and new medicines to treat them.

For Children Without Books, A New Chapter Begins

For the man behind Bernie’s Book Bank, putting books into kids' hands isn't just a battle to increase literacy in underserved communities. It's a personal quest.

What’s Not Normal About That Time of the Month

Unearthing what is and isn’t normal about that time of the month may be the key to empowering women to discuss endometriosis.

Growing a Passion for Science

The first step to encouraging students to pursue STEM careers is helping them see the work – and themselves – in a new light.